Myokines, like irisin and myostatin, could be useful markers for the assessment of disorders of the muscle-bone unit and metabolic bone diseases or even therapeutic targets for the treatment of sarcopenia and osteoporosis. Here, FNDC5 is linked to osteoporosis.